Question 1

What is Cartesian Therapeutics Inc. (RNAC) stock price today?

Accepted Answer

Cartesian Therapeutics Inc. (RNAC) currently trades at $6.22 per share. The stock has a market capitalization of $199.26M and a P/E ratio of —x.

Question 2

Is RNAC stock a buy, sell, or hold in 2026?

Accepted Answer

Based on WallStSmart's proprietary analysis, Cartesian Therapeutics Inc. has a Smart Value Score of 18/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

Question 3

What is Cartesian Therapeutics Inc.'s revenue and earnings?

Accepted Answer

Cartesian Therapeutics Inc. has trailing twelve-month (TTM) revenue of $2.80M with profit margins of 0.00%. Earnings per share (EPS) is $-5.02.

Question 4

Is RNAC stock overvalued or undervalued?

Accepted Answer

Based on our DCF model, Cartesian Therapeutics Inc.'s intrinsic value is $9.07, representing a margin of safety of 29.33%. The stock currently trades at a P/E of —x.

Metric	2022	2023	2024	2025	TTM
Revenue	$110.78M	$26.00M	$38.91M	$2.80M	$2.80M
Net income	$35.38M	$-219.71M	$-77.42M	$-130.30M	$-92.58M
EPS	—	—	—	—	$-5.02
Free cash flow	$-32.83M	$-51.37M	$-32.77M	$-79.39M	$-18.20M
Profit margin	31.94%	-844.91%	-198.97%	-4,658.63%	—

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
RNAC	$199.26M	18	4.0	2.5	6.0	5.0	+29.33%	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$322.34B	54	5.3	5.5	7.3	4.8	+42.06%	Buy
AZN	$294.17B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Cartesian Therapeutics Inc.

WallStSmart proprietary scores

Price targets

Price chart

X-Ray snapshot

Key financials

Peer comparison

Smart narrative

Frequently asked questions

Company info

Quick metrics

Performance

Compare